BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15377936)

  • 1. Predicting healthcare costs in a population of veterans affairs beneficiaries using diagnosis-based risk adjustment and self-reported health status.
    Pietz K; Ashton CM; McDonell M; Wray NP
    Med Care; 2004 Oct; 42(10):1027-35. PubMed ID: 15377936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing self-reported health status and diagnosis-based risk adjustment to predict 1- and 2 to 5-year mortality.
    Pietz K; Petersen LA
    Health Serv Res; 2007 Apr; 42(2):629-43. PubMed ID: 17362210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting costs of care using a pharmacy-based measure risk adjustment in a veteran population.
    Sales AE; Liu CF; Sloan KL; Malkin J; Fishman PA; Rosen AK; Loveland S; Paul Nichol W; Suzuki NT; Perrin E; Sharp ND; Todd-Stenberg J
    Med Care; 2003 Jun; 41(6):753-60. PubMed ID: 12773841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic, pharmacy-based, and self-reported health measures in risk equalization models.
    Stam PJ; van Vliet RC; van de Ven WP
    Med Care; 2010 May; 48(5):448-57. PubMed ID: 20393368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The performance of administrative and self-reported measures for risk adjustment of Veterans Affairs expenditures.
    Maciejewski ML; Liu CF; Derleth A; McDonell M; Anderson S; Fihn SD
    Health Serv Res; 2005 Jun; 40(3):887-904. PubMed ID: 15960696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Rx-defined morbidity groups and diagnosis- based risk adjusters for predicting healthcare costs in Taiwan.
    Kuo RN; Lai MS
    BMC Health Serv Res; 2010 May; 10():126. PubMed ID: 20478026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating diagnosis-based case-mix measures: how well do they apply to the VA population?
    Rosen AK; Loveland S; Anderson JJ; Rothendler JA; Hankin CS; Rakovski CC; Moskowitz MA; Berlowitz DR
    Med Care; 2001 Jul; 39(7):692-704. PubMed ID: 11458134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating diagnosis-based risk-adjustment methods in a population with spinal cord dysfunction.
    Warner G; Hoenig H; Montez M; Wang F; Rosen A
    Arch Phys Med Rehabil; 2004 Feb; 85(2):218-26. PubMed ID: 14966705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of statistical models to predict mental health and substance abuse cost.
    Montez-Rath M; Christiansen CL; Ettner SL; Loveland S; Rosen AK
    BMC Med Res Methodol; 2006 Oct; 6():53. PubMed ID: 17067394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Veterans Short Form 36 questionnaire is predictive of mortality and health-care utilization in a population of veterans with a self-reported diagnosis of asthma or COPD.
    Sprenkle MD; Niewoehner DE; Nelson DB; Nichol KL
    Chest; 2004 Jul; 126(1):81-9. PubMed ID: 15249446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic cost groups (DCGs) and concurrent utilization among patients with substance abuse disorders.
    Rosen AK; Loveland SA; Anderson JJ; Hankin CS; Breckenridge JN; Berlowitz DR
    Health Serv Res; 2002 Aug; 37(4):1079-103. PubMed ID: 12236385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case-mix classification system for explaining healthcare costs using administrative data in Italy.
    Corti MC; Avossa F; Schievano E; Gallina P; Ferroni E; Alba N; Dotto M; Basso C; Netti ST; Fedeli U; Mantoan D
    Eur J Intern Med; 2018 Aug; 54():13-16. PubMed ID: 29514743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the predictive validity of diagnosis-based risk adjusters for clinical outcomes.
    Petersen LA; Pietz K; Woodard LD; Byrne M
    Med Care; 2005 Jan; 43(1):61-7. PubMed ID: 15626935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life predicts future health care utilization and mortality in veterans with self-reported physician-diagnosed arthritis: the veterans arthritis quality of life study.
    Singh JA; Nelson DB; Fink HA; Nichol KL
    Semin Arthritis Rheum; 2005 Apr; 34(5):755-65. PubMed ID: 15846592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Explaining prescription drug use and expenditures using the adjusted clinical groups case-mix system in the population of British Columbia, Canada.
    Hanley GE; Morgan S; Reid RJ
    Med Care; 2010 May; 48(5):402-8. PubMed ID: 20393369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An in-depth assessment of a diagnosis-based risk adjustment model based on national health insurance claims: the application of the Johns Hopkins Adjusted Clinical Group case-mix system in Taiwan.
    Chang HY; Weiner JP
    BMC Med; 2010 Jan; 8():7. PubMed ID: 20082689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a psychiatric case-mix system.
    Sloan KL; Montez-Rath ME; Spiro A; Christiansen CL; Loveland S; Shokeen P; Herz L; Eisen S; Breckenridge JN; Rosen AK
    Med Care; 2006 Jun; 44(6):568-80. PubMed ID: 16708006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the Role of Past Clinical Information on Risk Adjustment.
    Lin JK; Hong J; Phibbs C; Almenoff P; Wagner T
    Med Care; 2020 Feb; 58(2):169-173. PubMed ID: 31688567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of case-mix measures derived from self-reports of diagnoses and health.
    Fan VS; Au D; Heagerty P; Deyo RA; McDonell MB; Fihn SD
    J Clin Epidemiol; 2002 Apr; 55(4):371-80. PubMed ID: 11927205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Adjustment Tools for Learning Health Systems: A Comparison of DxCG and CMS-HCC V21.
    Wagner TH; Upadhyay A; Cowgill E; Stefos T; Moran E; Asch SM; Almenoff P
    Health Serv Res; 2016 Oct; 51(5):2002-19. PubMed ID: 26839976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.